Last updated: January 9, 2025
Sponsor: Aspa Therapeutics
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04126005
CVN-101
CANinform
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Meet age criteria of a specific cohort.
Confirmed clinical and biochemical diagnosis of Canavan disease.
Available medical records since birth that permit documentation of diseasecharacteristics and developmental milestones.
Parent and/or legal guardian is able to read, understand, and sign the informedconsent.
Exclusion
Exclusion Criteria:
- Patient does not meet the Inclusion Criteria.
Study Design
Total Participants: 70
Study Start date:
October 10, 2019
Estimated Completion Date:
April 30, 2026
Study Description
Connect with a study center
University Medical Center Hamburg-Eppendorf
Hamburg, 20246
GermanyActive - Recruiting
UCSF Benioff Children's Hospital Oakland
Oakland, California 94609
United StatesActive - Recruiting
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available
NYU Langone Medical Center
New York, New York 10016
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.